Les inscriptions sont ouvertes pour notre programme de 4 mois à temps plein, à Mila, conçu spécifiquement pour les fondateurs et fondatrices de la deep tech issus de parcours d'élite en STIM. Vous avez jusqu'au 21 novembre 2026 pour appliquer!
La prochaine rencontre, qui aura lieu le 10 novembre à Mila, permettra d'explorer comment pouvons-nous collectivement développer, encadrer et déployer des systèmes agentiques performants, fiables et sécuritaires en connectant chercheur·euse·s académiques, expert·e·s industriel·le·s et praticien·ne·s.
Le processus de demandes de supervision à Mila est maintenant ouvert! Vous pouvez appliquer dès maintenant à la maitrise de recherche ou Doctorat et joindre notre grande communauté de chercheur·euse·s à Mila pour l’automne 2027. Date limite : 1er décembre 2026
Nous utilisons des témoins pour analyser le trafic et l’utilisation de notre site web, afin de personnaliser votre expérience. Vous pouvez désactiver ces technologies à tout moment, mais cela peut restreindre certaines fonctionnalités du site. Consultez notre Politique de protection de la vie privée pour en savoir plus.
Paramètre des cookies
Vous pouvez activer et désactiver les types de cookies que vous souhaitez accepter. Cependant certains choix que vous ferez pourraient affecter les services proposés sur nos sites (ex : suggestions, annonces personnalisées, etc.).
Cookies essentiels
Ces cookies sont nécessaires au fonctionnement du site et ne peuvent être désactivés. (Toujours actif)
Cookies analyse
Acceptez-vous l'utilisation de cookies pour mesurer l'audience de nos sites ?
Lecteur Multimédia
Acceptez-vous l'utilisation de cookies pour afficher et vous permettre de regarder les contenus vidéo hébergés par nos partenaires (YouTube, etc.) ?
Olivier Lefebvre
Alumni
Publications
Diagnosing Low-Confidence Patient Profiles via Localized Harmful Covariate Shift Detection
Before deploying clinical prediction models, their reliability must be assessed to ensure safe use. Errors may arise from distribution shift… (voir plus)s between training and deployment or from heterogeneous performance where the model systematically underperforms for certain patient subgroups. Yet most post-hoc diagnostic methods evaluate reliability only at the population level, checking whether the deployment data resemble the training data and whether the model performs well on average, without accounting for heterogeneity that may cause some patients to be disproportionately affected. We propose a unified diagnostic pipeline that combines both perspectives. MED3pa first discovers interpretable low-confidence patient profiles, and Detectron is then applied within each profile to test whether its degradation is associated with a detectable harmful covariate shift. Across three clinical prediction tasks and three injected subgroup shifts in MIMIC-IV, we find that shift detectability itself is informative. An injected age shift, undetectable at the population level, was nonetheless localized to specific degraded profiles, whereas sex- and race-related shifts were detected broadly and therefore offered little guidance for identifying the most affected patients.
Artificial Intelligence models are increasingly used in healthcare, yet global performance metrics can mask variations in reliability across… (voir plus) individual patients or subgroups with shared attributes, called
patient profiles
. This study introduces MED3pa, a method that identifies when models are less reliable, allowing clinicians to better assess model limitations.
We propose a framework that estimates predictive confidence using three combined approaches: Individualized (IPC), Aggregated (APC), and Mixed Predictive Confidence (MPC). IPC estimates confidence for each patient, APC assesses it across profiles, and MPC combines both. We evaluate our method on four datasets: one simulated, two public, and one private clinical dataset. Metrics by Declaration Rate (MDR) curves show how performance changes when retaining only the most confident predictions, while interpretable decision trees reveal profiles with higher or lower model confidence.
We demonstrate our method in internal, temporal, and external validation settings, as well as through a clinical example. In internal validation, limiting predictions to the 93% most confident cases improved sensitivity by 14.3% and the AUC by 5.1%. In the clinical example, MED3pa identified a patient profile with high misclassification risk, demonstrating its potential for safer deployment.
By identifying low-confidence predictions, our framework improves model reliability in clinical settings. It can be integrated into decision support systems to help clinicians make more informed decisions. Confidence thresholds help balance model performance with the proportion of patients for whom predictions are considered reliable.
Better leveraging confidence in model predictions could improve reliability and trustworthiness, supporting safer and more effective use in healthcare.